Clover Health Investments, Corp.
CLOV· Nasdaq
Released May 7, 2024, after the close
10-Q filed May 7, 2024, 37 days after period end · 0001801170-24-000102
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $346.92M | $321.99M | $874.38M | $200.33M |
| Net Income | -$19.17M | -$72.61M | -$75.49M | -$48.42M |
| EPS Diluted |
Clover Health Investments, Corp. · CIK 1801170 · Engraved from SEC EDGAR
| -$0.05 |
| -$0.15 |
| -$0.16 |
| -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.